AR Asset Management Inc. Has $4.67 Million Stock Holdings in Johnson & Johnson $JNJ

AR Asset Management Inc. trimmed its stake in Johnson & Johnson (NYSE:JNJ) by 1.6% during the second quarter, Holdings Channel reports. The fund owned 30,597 shares of the company’s stock after selling 506 shares during the quarter. Johnson & Johnson accounts for 1.0% of AR Asset Management Inc.’s holdings, making the stock its 29th largest position. AR Asset Management Inc.’s holdings in Johnson & Johnson were worth $4,674,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of JNJ. GFG Capital LLC bought a new position in shares of Johnson & Johnson in the second quarter worth about $35,000. Stone House Investment Management LLC acquired a new stake in Johnson & Johnson during the first quarter worth about $47,000. 1248 Management LLC acquired a new stake in shares of Johnson & Johnson during the 1st quarter worth approximately $48,000. Harvest Fund Management Co. Ltd bought a new position in Johnson & Johnson in the first quarter worth $52,000. Finally, Pandora Wealth Inc. acquired a new stake in Johnson & Johnson during the first quarter worth $65,000. Institutional investors own 69.55% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on JNJ. HSBC raised their target price on Johnson & Johnson from $210.00 to $215.00 and gave the stock a “buy” rating in a research report on Thursday, October 16th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Johnson & Johnson in a research note on Friday, October 31st. The Goldman Sachs Group boosted their price objective on shares of Johnson & Johnson from $186.00 to $212.00 and gave the stock a “buy” rating in a research report on Thursday, October 9th. JPMorgan Chase & Co. boosted their target price on Johnson & Johnson from $185.00 to $200.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 16th. Finally, Sanford C. Bernstein raised their target price on shares of Johnson & Johnson from $172.00 to $193.00 and gave the company a “market perform” rating in a research note on Monday, October 6th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Johnson & Johnson presently has a consensus rating of “Moderate Buy” and an average price target of $199.05.

Insiders Place Their Bets

In related news, EVP Jennifer L. Taubert sold 56,471 shares of the business’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the sale, the executive vice president directly owned 178,013 shares in the company, valued at $31,652,491.53. The trade was a 24.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.16% of the company’s stock.

Johnson & Johnson Stock Performance

Shares of JNJ stock opened at $186.89 on Wednesday. The company’s fifty day simple moving average is $183.64 and its 200-day simple moving average is $168.16. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $194.48. The company has a quick ratio of 0.80, a current ratio of 1.07 and a debt-to-equity ratio of 0.50. The firm has a market cap of $450.27 billion, a PE ratio of 18.04, a P/E/G ratio of 2.19 and a beta of 0.40.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. The business had revenue of $24.02 billion for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. Equities research analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 25th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $5.20 annualized dividend and a dividend yield of 2.8%. Johnson & Johnson’s dividend payout ratio is presently 50.19%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.